TAL - STEM TGTX SHAK and EDU among premarket gainers
AnPac Bio-Medical Science (ANPC) +29% on launching novel Cancer treatment technology and product JV.Pieris Pharmaceuticals (PIRS) +21% on collaboration with Genentech.Ault Global Holdings (DPW) +14% on Q1 results.Taiwan Liposome Company (TLC) +13% as its application for AmphoTLC approved in India.New Oriental Education & Technology Group (EDU) +12%.TAL Education Group (TAL) +10%.Luokung Technology (LKCO) +8%.TG Therapeutics (TGTX) +7% as FDA accepts its application for ublituximab + ukoniq.GSX Techedu (GOTU) +7%.UP Fintech Holding Limited (TIGR) +7% on Q1 results.FinVolution Group (FINV) +7% on Q1 results.EyeGate Pharmaceuticals (EYEG) +5%.Pluristem Therapeutics (PSTI) +6% following €20M funding from European Investment Bank.Stem (STEM) +6% on Goldman Sachs Buy initiation with PT $30Urban Tea (MYT) +6%.Shake Shack (SHAK) +6%.Assertio Holdings (ASRT) +5%.
For further details see:
STEM, TGTX, SHAK and EDU among premarket gainers